摘要
观察复方丹参注射液联用氦 氖激光血管内照射 (ILIB)治疗老年急性脑梗死患者的临床疗效。方法 :复方丹参注射液联用ILIB治疗 40例 (治疗组 )与单用复方丹参注射液治疗 6 0例 (对照组 ) ,qd ,疗程均为 2 0d ,观察疗效及血液流变学指标的变化。结果 :治疗组治愈 35例 (87.5 % ) ,好转 5例 (12 .5 % ) ;对照组治愈 42例 (70 .0 % ) ,好转 16例(2 6 .7% ) ,治疗组治愈率显著优于对照组 (P <0 .0 5 )。治疗组血液流变学指标的改善也优于对照组。结论 :两组治疗老年急性脑梗死疗效均较满意 ,但治疗组疗效优于对照组。
Objective:To observe the clinical efficiency of Compound Danshen Injection combined with intravascular He-Ne laser irradiation blood (ILIB) in the treatment of senile acute cerebral infarction (ACI). Methods:40 cases of senile ACI were treated with Compound Danshen Injection combined with ILIB (treated group) and 60 cases with Compound Danshen Injection alone (controlled group), all cases received once daily, 20 times were served as a therapy course. Then, the efficacy of the treatment and changes of hemorrheologic parameters were observed. Results:In treated group, 35 cases were cured and 5 cases were improved; in controlled group, 42 cases were cured and 16 cases were improved, the cured rate in the former (87.5%) was superior to the later (70.0%, P<0.05); the improvement of hemorrhelolgic parameters in treated group were also superior to the controlled group. Conclusions:Both groups have same satisfactory efficiency in treatment senile ACI, but the obvious degree of therapeutic efficacy in treated group is superior to that of the controlled group.
出处
《医药导报》
CAS
2000年第3期222-223,共2页
Herald of Medicine
关键词
脑梗塞
复方丹参液
血管内激光照射
老年人
治疗
Compound Danshen Injection Intavascular He-Ne laser irradiation blood Cerebral infarction,acute/senile
